ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,055Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 17

$863K Total Retail Price of All Prescriptions

Rank: 4 out of 17

260 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 260 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

5% of this provider’s 260 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 15,806 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

62 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
FUROSEMIDE 954 942 1 2
LEVOTHYROXINE SODIUM 699 685 2 1
LISINOPRIL 513 512 3 3
METOPROLOL TARTRATE 478 466 4 7
AMLODIPINE BESYLATE 458 457 5 6
DONEPEZIL HCL 454 453 6 8
LIDODERM 380 380 7 18
OMEPRAZOLE 372 371 8 9
QUETIAPINE FUMARATE 357 357 9 15
NAMENDA 347 347 10 12
MIRTAZAPINE 326 326 11 13
WARFARIN SODIUM 308 308 12 4
CITALOPRAM HBR 307 294 13 14
SIMVASTATIN 216 190 14 5
GLIPIZIDE 214 214 15 57
TRAZODONE HCL 210 190 16 17
TRAMADOL HCL 209 191 17 21
IPRATROPIUM-ALBUTEROL 201 201 18 16
VENLAFAXINE HCL ER 200 193 19 25
CEPHALEXIN 199 195 20 54
METOPROLOL SUCCINATE 171 171 21 11
GABAPENTIN 167 166 22 10
DIOVAN 166 166 23 36
POTASSIUM CHLORIDE 154 154 24 23
KLOR-CON M20 151 151 25 35
ATORVASTATIN CALCIUM 151 151 25 20
NYSTOP 144 136 27 40
CYMBALTA 141 118 28 32
LANTUS 135 134 29 34
POLYETHYLENE GLYCOL 3350 133 133 30 46
SERTRALINE HCL 130 130 31 22
MELOXICAM 127 127 32 43
FENTANYL 118 118 S2 33 90
ALENDRONATE SODIUM 110 110 34 31
GENERLAC 107 107 35 94
HYDROCHLOROTHIAZIDE 105 105 36 24
SEROQUEL 105 105 36 49
ATENOLOL 104 104 38 19
METFORMIN HCL 102 91 39 29
CARBIDOPA-LEVODOPA 100 100 40 45
RISPERIDONE 98 97 41 30
OLANZAPINE 96 96 42 48
ESCITALOPRAM OXALATE 90 90 43 28
PROMETHAZINE HCL 89 85 R 44 60
AZITHROMYCIN 89 89 44 77
ERYTHROMYCIN 88 88 46 96
NITROFURANTOIN MONO-MACRO 84 84 47 99
PANTOPRAZOLE SODIUM 79 79 48 39
ADVAIR DISKUS 78 78 49 27
CEFDINIR 77 77 50 100
ALLOPURINOL 77 77 50 37
OXYBUTYNIN CHLORIDE ER 76 75 52 55
DIVALPROEX SODIUM 74 74 53 65
ISOSORBIDE MONONITRATE ER 73 73 54 41
TRAVATAN Z 70 70 55 52
LOSARTAN POTASSIUM 68 68 56 47
PREDNISONE 68 68 56 26
NYSTATIN 67 67 58 56
KLOR-CON M10 66 66 59 58
AVELOX 64 64 60 69
HYDROCODONE-ACETAMINOPHEN 63 63 S3 61 33
CEFTRIAXONE 63 63 61 106
CLOPIDOGREL 62 62 63 61
PRAVASTATIN SODIUM 62 62 63 51
AMIODARONE HCL 61 61 65 87
ROPINIROLE HCL 60 60 66 50
ENULOSE 56 56 67 89
TIMOLOL MALEATE 55 55 68 75
CLOTRIMAZOLE-BETAMETHASONE 55 55 68 76
HYDROCORTISONE 54 53 70 116
LIDOCAINE HCL 54 54 70 116
ISOSORBIDE DINITRATE 53 53 72 118
LATANOPROST 53 53 72 67
PLAVIX 52 52 74 86
SPIRIVA 51 51 75 42
HYDROXYZINE HCL 51 51 R 75 124
OXYCODONE-ACETAMINOPHEN 50 50 S2 77 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.